We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Pasteur Wins $97 Million HHS Contract to Develop Cell-Based Vaccines
Sanofi Pasteur Wins $97 Million HHS Contract to Develop Cell-Based Vaccines
April 1, 2005
The HHS has awarded a $97 million contract to sanofi pasteur to support the development of cell culture-based influenza vaccines, an advanced type of flu vaccine the agency hopes can be manufactured faster and in larger volumes than traditional egg-based vaccines.